Free CME from PeerView


Pulmonary/Respiratory Medicine CME

Credits: 0.70 CME
Purdue University
Changing the Treatment Story With Hormonal Therapy in Prostate Cancer: Challenges and Opportunities for Improving Care Across Disease Settings
Neal D. Shore, MD, FACS
December 30, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Reducing the Burden of Chronic Rhinosinusitis With Nasal Polyps on Patient Quality of Life: An Exploration of Novel and Emerging Biologic Therapy
Jonathan Corren, MD
December 30, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
A Visual Exploration of New Opportunities in Thyroid Cancer: Targeting RET Alterations to Optimize Outcomes
Marcia S. Brose, MD, PhD
December 30, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Targeting Ocular Toxicity in Multiple Myeloma: Opportunities for Ophthalmology-Oncology Collaboration
Sagar Lonial, MD, FACP
December 29, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Improving Outcomes and Preventing Chronic Kidney Disease Progression: Evaluating the Role of Novel Nonsteroidal Mineralocorticoid Receptor Antagonists
George L. Bakris, MD
December 29, 2020
Credits: 1.50 CME
Penn State College of Medicine
How I Think, How I Treat in the New Age of AML Care: Personal Perspectives on New Evidence and Innovative Therapeutics
Tara Lin, MD
December 24, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Rewriting Patient Care in Mantle Cell Lymphoma: How Innovative Therapy Is Poised to Challenge Conventional Treatment
Ian W. Flinn, MD, PhD
December 24, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Exploring Antibody Therapy in ALL: How and Why to Integrate Antibody-Based Treatment Into Patient Management
Professor David I. Marks, MB, MS, FRACP, PhD, FRCPath
December 24, 2020
Credits: 1.50 CME
Penn State College of Medicine
Building New Management Models for NHL Care: Tumor Board Insights on Innovative Therapeutics in FL and DLBCL
Nathan H. Fowler, MD
December 23, 2020
Credits: 1.50 CME
Penn State College of Medicine
Mapping the New Era in CLL Management: Precision Medicine and Patient Perspectives in Treatment-Naïve and Relapsed Disease
John G. Gribben, MD, DSc, FRCP, FRCPath, FMedSci
December 23, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Preparing for Personalized Care in Myelodysplastic Syndromes: Integrating Innovative Treatments Into a Cohesive Patient Care Model
Steven D. Gore, MD
December 23, 2020
Credits: 1.00 CME / MOC
Penn State College of Medicine
Understanding the Evolving Treatment Landscape in Prostate Cancer: How to Leverage the Latest Advances and Strategies to Optimize Patient Outcomes
William K. Oh, MD
December 22, 2020
Credits: 1.25 CPE
Medical Learning Institute, Inc.
HIF-PH Inhibitors for Anemia in Chronic Kidney Disease: What Are Their Implications in Health-System Pharmacy?
December 22, 2020
Credits: 1.50 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1 and Plexiform Neurofibromas: Improving Patient Outcomes With an Innovative Therapeutic Approach
Bruce R. Korf, MD, PhD
December 18, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Making the Case for Treating Iron Deficiency in Patients With Heart Failure
Javed Butler, MD, MPH, MBA
December 9, 2020
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
Personalizing and Prolonging Care in GIST: Expert Guidance on Integrating New TKI Strategies
Margaret von Mehren, MD
December 8, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
The Case for Challenging Conventional Care in Tenosynovial Giant Cell Tumor: Insights on Integrating Targeted Therapy Into Multimodal Management
William D. Tap, MD
December 7, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Navigating the Relationship Between Type 2 Inflammation and Uncontrolled, Moderate to Severe Asthma: Identifying Eligible Patients for Targeted Biologic Therapy
Professor Ian M. Adcock, PhD, FRSB, FBPhS, FERS
December 7, 2020
Credits: 0.50 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Understanding the Relationship Between Type 2 Inflammation, Atopic Diseases, and Treatment Selection: Practical Strategies for the Healthcare Team to Improve Patient Care
Jonathan A. Bernstein, MD
December 4, 2020
Credits: 0.50 CME / NCPD / CPE
Penn State College of Medicine / Medical Learning Institute, Inc.
Management of Hyperkalemia in Patients With Hemodialysis-Dependent Chronic Kidney Disease: Applying New Evidence and Best Practices for Improved Patient Outcomes
Steven Fishbane, MD
December 3, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Unraveling the Intricacies of HCC Management With Your Multidisciplinary Team: A Closer Look at Effective Selection and Sequencing Strategies in an Expanding Treatment Landscape
Amit Singal, MD, MS
December 1, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Everything You Need to Know About Molecular Testing and Targeted Therapies in NSCLC: Essential Guidance for Modern Patient-Centered Precision Lung Cancer Care
Suresh S. Ramalingam, MD, FACP, FASCO
November 30, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Improving Recognition and Management of EGPA: A Multidisciplinary Approach to Individualizing Treatment
Eric Gapud, MD, PhD
November 30, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
The Evolving Treatment Landscape of SSc-ILD: Strategies to Improve Recognition and Management
Flavia Castelino, MD
November 25, 2020
Credits: 1.00 CME / MOC
PeerView Institute
Solutions for Tenosynovial Giant Cell Tumors: Employing Effective Multimodal and Multidisciplinary Approaches to Patient Care
Robin L. Jones, MD
November 20, 2020
Credits: 1.50 CME / MOC / CNE
PeerView Institute
Emergency Department on Alert: Solving Oncologic Emergency Quandaries During the Immuno-Oncology Era and COVID-19 Pandemic
Jarushka Naidoo, MB, BCH, MHS / Andrew Stolbach, MD, MPH
November 20, 2020
Credits: 1.00 CME
PeerView Institute
Modernizing Your Radiation Oncology Practice With Tumor Treating Fields and Other Novel Multimodal Strategies: Understanding the Science, Evidence, and Practical Aspects Across a Range of Solid Tumors
Hani M. Babiker, MD
November 12, 2020
Credits: 1.50 CME / MOC / CNE / CPE
PeerView Institute
Immunotherapy in the Treatment Arsenal for Small Cell Lung Cancer, and Managed Care Implications for the Four Ps: Patient, Provider, Pharmacy, and Plan
Stephen V. Liu, MD
Bhavesh Shah, RPh, BCOP
November 12, 2020
Credits: 1.00 CME
PeerView Institute
Turning Tides in Targeted Therapy for Early-Stage EGFR-Mutated NSCLC: Latest Data and Practical Guidance for Thoracic Surgeons and the Multidisciplinary Team on the Emerging Role of EGFR-Targeted Therapy in Resectable Lung Cancer
David R. Jones, MD
November 11, 2020
Credits: 0.50 CME
PeerView Institute
Addressing Challenges in the Treatment of Nontuberculous Mycobacterial Lung Disease: Managing Adverse Effects to Keep Patients on Therapy
Gwen A. Huitt, MD, MS
November 9, 2020

Pages

Upcoming Live Events

Education Collections


Recent CME Podcast

More Podcasts from PeerView